NeurologyLive® Friday 5 — August 30, 2024

Welcome to NeurologyLive^®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive^®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Raising Awareness for Spinal Muscular Atrophy and Improving Newborn Screening: Crystal Proud, MD

The director of neurology and neuromuscular medicine at the Children’s Hospital of the King’s Daughters in Norfolk, Virginia, discussed SMA Awareness Month and the enhancements to newborn screening for the disease. [WATCH TIME: 4 minutes]

2: Alzheimer Disease: Promising Advances Give Patients and Families Hope

William Hu, MD, PhD, FAAN, a neurologist at RWJBarnabas Health’s Robert Wood Johnson University Hospital in New Brunswick, NJ, shared new advances to detect and treat Alzheimer disease.

3: Personalized Medicine: Predicting the Transition to Secondary Progressive Multiple Sclerosis

The postdoctoral researcher at Amsterdam University Medical Center introduces the DAAE score, a tool used to predict a patient's risk of transition to secondary progressive multiple sclerosis.

4: NeuroVoices: Dirk Thye, MD, on Challenges and Progress in Treating Ataxia Telangiectasia With EryDex

The chief executive officer and chief medical officer at Quince Therapeutics talked about recent findings from the phase 3 ATTeST study assessing EryDex in pediatric patients with ataxia telangiectasia.

5: The Journey of Abbott’s Blood Test for Traumatic Brain Injury to the Clinical Setting: Linda Papa, MD, MSc, CCFP, FRCP(C), FACEP

The director of academic clinical research at Orlando Health reflected on the journey of a blood test for traumatic brain injury to clinical use, highlighting the collaborative efforts and patient participation that made it possible. [WATCH TIME: 3 minutes]